Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced preclinical test results that showed Telomir-1 reversed multiple symptoms in an animal model of Wilson's disease. These results provide further proof of the potential of Telomir-1 to reduce aging-related diseases.
